Archives

Perfusfind S.L.

Abstract PRINCETON, N.J., Nov. 2, 2022 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: ), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using its CytoSorb® blood purification technology,..

Perfusfind S.L.

Abstract The primary objective was to investigate the association between partial pressure of carbon dioxide (PaCO2) change after extracorporeal membrane oxygenation (ECMO) initiation and neurologic outcome in neonates treated for respiratory..

Perfusfind S.L.

Abstract Background: Survival rates in refractory out-of-hospital cardiac arrest (OHCA) remain low with conventional advanced cardiac life support (ACLS). Extracorporeal life support (ECLS) implantation during ongoing resuscitation, a method called..

Perfusfind S.L.

Abstract Extracorporeal membrane oxygenation (ECMO), which can support gas exchange or hemodynamics in patients with severe respiratory or cardiac failure, has demonstrated considerable evolution over the last decade [], with..

Perfusfind S.L.

Abstract Extracorporeal membrane oxygenation (ECMO) is becoming a common procedure to support patients with severe cardio-circulatory or respiratory failure as well as in case of combined compromise of the two..

Perfusfind S.L.

Abstract Objectives Simultaneous mechanical  (MCS) with intra-aortic balloon pump (IABP) to  (ECMO) is common in postcardiotomy  (PCS). This study aimed to analyse the effect of concomitant ECMO and IABP therapy on the short-term..

Perfusfind S.L.

Abstract CentriMag® extracorporeal VAD support could represent a more physiological choice than conventional ECMO in primary cardiogenic shock. We therefore evaluated the outcome of patients with primary cardiogenic shock who were..

Perfusfind S.L.

Abstract Background: Postcardiotomy cardiogenic shock (PCS) that is refractory to inotropic support remains a major concern in cardiac surgery and is almost universally fatal unless treated with mechanical support. While reported..

Perfusfind S.L.

Abstract Purpose Preoptimizing the hemodynamics and volume status prior to heart transplant is essential for the outcome. Temporary mechanical circulatory support (MCS) has been expanding especially after recent changes to..

Perfusfind S.L.

Abstract Importance  Extracorporeal membrane oxygenation (ECMO) is used as temporary cardiorespiratory support in critically ill patients, but little is known regarding long-term psychiatric sequelae among survivors after ECMO. Objective  To investigate the..

Perfusfind S.L.

Abstract Background: The benefit of the combined use of an intra-aortic balloon pump (IABP) and venoarterial extracorporeal membrane oxygenation (VA-ECMO) for postcardiotomy shock remains unclear. We aimed to analyse the potential..

Perfusfind S.L.

Abstract Venoarterial extracorporeal membrane oxygenation (VA ECMO) is an effective mechanical circulatory support for cardiopulmonary failure. Conventionally, an arterial cannula over 15 Fr is inserted for full circulatory support in..

Perfusfind S.L.

Abstract Burns are among the leading causes of trauma worldwide, and acute respiratory distress syndrome (ARDS) is a common cause of death in burn patients. Some patients develop hypoxemia refractory..

Perfusfind S.L.

Abstract We applied the Society for Cardiovascular Angiography and Interventions (SCAI) schema to cardiogenic shock (CS) patients treated with venoarterial extracorporeal membrane oxygenation (VA-ECMO) to assess performance in this high..

Perfusfind S.L.

Abstract Focused cardiac ultrasound is an important aspect of the comprehensive management of patients with cardiac arrest, especially in patients selected for extracorporeal cardiopulmonary resuscitation (eCPR). It guides physician during..

Perfusfind S.L.

Abstract Background Venovenous extracorporeal membrane oxygenation (ECMO) can be considered for patients with COVID-19-associated acute respiratory distress syndrome (ARDS) who continue to deteriorate despite evidence-based therapies and lung-protective ventilation. The..

Perfusfind S.L.

Abstract Background and purpose Extracorporeal membrane oxygenation (ECMO) continues to play an essential role in organ support in cardiogenic shock or acute respiratory distress syndrome and bridging to transplantation. The..

Perfusfind S.L.

Abstract Rationale: Data are suggesting that altered antimicrobial concentrations are likely during extracorporeal membrane oxygenation (ECMO). Objectives: The primary aim of this analysis was to describe the pharmacokinetics of antimicrobials..

Perfusfind S.L.

Abstract In September 2020, researchers from the University Heart and Vascular Center Hamburg, Department of Cardiovascular Surgery, and Department of Cardiology/Electrophysiology described their technique for laser lead extraction during VA-ECMO..

Perfusfind S.L.

Abstract Objectives Refractory hypoxemia can occur in patients with acute respiratory distress syndrome from COVID-19 despite support with venovenous (VV) extracorporeal membrane oxygenation (ECMO). Parallel ECMO circuits can be used..

Perfusfind S.L.

Abstract The Acute Respiratory Distress Syndrome (ARDS) is common in patients on the Intensive Care Unit and associated with significant mortality rates. In situations of severe respiratory insufficiency and failure..

Perfusfind S.L.

Abstract Idiopathic inflammatory myopathies (IIM), including dermatomyositis (DM) and polymyositis (PM), have a reported mortality rate of 28.6% despite immunosuppressive therapies. IIMs are complicated by interstitial lung disease (ILD) in 41%..

Perfusfind S.L.

Abstract Patients receiving extracorporeal membrane oxygenation (ECMO) often suffer from acute kidney injury (AKI), requiring continuous renal replacement therapy (CRRT). In our clinical practice, we connected the inlet line of..

Perfusfind S.L.

Abstract Nitric oxide (NO) incorporation into the sweep gas of the extracorporeal life support (ECLS) circuit has been proposed as a strategy to ameliorate the insults caused by the systemic..

Perfusfind S.L.

Abstract Over the last several years, the use of extracorporeal membrane oxygenation (ECMO) has exponentially increased. As the technology advanced, the rate of devastating complications has decreased somewhat, and the..

Perfusfind S.L.

Abstract Background Clinical trials inform on average efficacy, but individualized risk assessments for outcome prediction are important in guiding treatment implementation. Objectives The authors developed and validated a patient-specific risk..

Perfusfind S.L.

Abstract Purpose Dual-lumen  (ECMO)  is considered technically challenging and harbors the risk of potential life-threatening complications during cannulation. Dual-lumen  insertion is performed under either ultrasound or  guidance. Both techniques have significant disadvantages, such as..

Perfusfind S.L.

Abstract Extracorporeal membrane oxygenation (ECMO) has become an important therapeutic approach in the COVID-19 pandemic. The development and research in this field strongly relies on animal models; however, efforts are..

Perfusfind S.L.

Abstract Background Shock severity predicts mortality in patients with cardiogenic shock (CS). We evaluated the association between pre-cannulation Society for Cardiovascular Angiography and Interventions (SCAI) shock classification and mortality among..

Perfusfind S.L.

Abstract During a 6 week period beginning early March 2020, 30 patients with severe coronavirus disease 2019 (COVID-19) were supported with venovenous extracorporeal membrane oxygenation (ECMO). This volume increase mandated..